Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Allen Helliwell Insider Profile
60 Followers
James Allen Helliwell, Chief Executive Officer at Eupraxia Pharmaceuticals, holds 674.01K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, James Allen Helliwell Bought C$14,286 shares of Eupraxia Pharmaceuticals on Aug 21, 2023 for an estimated value of 100.00K.
James Allen Helliwell Eupraxia Pharmaceuticals (EPRX)Chief Executive Officer
Eupraxia Pharmaceuticals (EPRX)
Chief Executive Officer
Ranked #19 out of 98,624 Corporate Insiders
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+320.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Allen Helliwell's holdings
Insider Roles
Chief Executive Officer
Roles that James Allen Helliwell holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 04, 2022 - Jul 04, 2023
Return:+759.20%
The most profitable trade made by James Allen Helliwell
James Allen Helliwell's Trading History
List of latest transactions for each holding click on a transaction to see James Allen Helliwell's performance on stock
You May Also Like
James Allen Helliwell insider profile FAQ
What is the percentage of profitable transactions made by James Allen Helliwell?
The percentage of profitable transactions made by James Allen Helliwell is 80%.
What is the average return per transaction made by James Allen Helliwell?
The average return per transaction made by James Allen Helliwell is 320.00%.
What stocks does James Allen Helliwell hold?
James Allen Helliwell holds: TSE:EPRX stocks.
What was James Allen Helliwell’s latest transaction?
James Allen Helliwell latest transaction was an Informative Buy of C$100.00K.
What was James Allen Helliwell's most profitable transaction?
James Allen Helliwell’s most profitable transaction was an Informative Buy of TSE:EPRX stock on July 4, 2022. The return on the trade was 759.20%.
What is James Allen Helliwell's role in Eupraxia Pharmaceuticals?
James Allen Helliwell's role in Eupraxia Pharmaceuticals is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.